DIVA Laboratories, Ltd. (TPEX:4153)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
31.25
-0.15 (-0.48%)
Jun 3, 2026, 1:30 PM CST
Market Cap1.83B -25.4%
Revenue (ttm)884.63M +4.4%
Net Income90.43M -4.0%
EPS1.54 -3.7%
Shares Out 58.67M
PE Ratio20.27
Forward PEn/a
Dividend2.00 (6.37%)
Ex-Dividend DateJun 12, 2026
Volume67,068
Open31.15
Previous Close31.40
Day's Range31.00 - 31.75
52-Week Range29.50 - 43.95
Beta0.21
Analystsn/a
Price Targetn/a
Earnings DateJul 27, 2026

About DIVA Laboratories

DIVA Laboratories, Ltd. engages in the development, manufacture, and sale of medical equipment and computer related devices worldwide. The company provides endo/surgical displays, a static and dynamic image for hybrid and integrated ORs applications; color and mono displays for radiology and medical imaging applications; touch displays/human machine interface products; medical and industrial cases; and displays to original design manufacturers (ODM) and original equipment manufacturers (OEMs) customers. It also offers emergency room/ operating ... [Read more]

Sector Healthcare
Founded 1995
Employees 154
Stock Exchange Taipei Exchange
Ticker Symbol 4153
Full Company Profile

Financial Performance

In 2025, DIVA Laboratories's revenue was 868.84 million, an increase of 0.76% compared to the previous year's 862.32 million. Earnings were 90.54 million, a decrease of -3.33%.

Financial Statements